The secret to combating pancreatic cancer may lie in suppression of a common protein

(University of Southern California - Health Sciences) Research indicates that in mice with a KRAS mutation, present in 90 percent of pancreatic cancer patients, expressing only half the amount of the glucose-regulated protein GRP78 is enough to halt the earliest stage of pancreatic cancer development, resulting in delayed tumor development and prolonged survival.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news